180 related articles for article (PubMed ID: 21592346)
1. Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.
Kim D; Kwon S; Rhee JW; Kim KD; Kim YE; Park CS; Choi MJ; Suh JG; Kim DS; Lee Y; Kwon HJ
BMC Immunol; 2011 May; 12():29. PubMed ID: 21592346
[TBL] [Abstract][Full Text] [Related]
2. Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers.
Lee Y; Lee YS; Cho SY; Kwon HJ
Adv Protein Chem Struct Biol; 2015; 99():75-97. PubMed ID: 26067817
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA.
Kim D; Kwon S; Ahn CS; Lee Y; Choi SY; Park J; Kwon HY; Kwon HJ
BMB Rep; 2011 Nov; 44(11):758-63. PubMed ID: 22118544
[TBL] [Abstract][Full Text] [Related]
4. Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
Kwon S; Kim D; Park BK; Cho S; Kim KD; Kim YE; Park CS; Ahn HJ; Seo JN; Choi KC; Kim DS; Lee Y; Kwon HJ
PLoS One; 2012; 7(3):e33121. PubMed ID: 22427965
[TBL] [Abstract][Full Text] [Related]
5. Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA.
Kim D; Kwon HJ; Lee Y
BMB Rep; 2011 Sep; 44(9):607-12. PubMed ID: 21944255
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.
Rhee JW; Kim D; Park BK; Kwon S; Cho S; Lee I; Park MS; Seo JN; Kim YS; Choi HS; Lee Y; Kwon HJ
PLoS One; 2012; 7(11):e48750. PubMed ID: 23144954
[TBL] [Abstract][Full Text] [Related]
7. Production of Epitope-Specific Antibodies by Immunization with Synthetic Epitope Peptide Formulated with CpG-DNA-Liposome Complex Without Carriers.
Kim D; Lee Y; Kwon HJ
Methods Mol Biol; 2015; 1348():127-35. PubMed ID: 26424269
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibodies Against the Human Respiratory Syncytial Virus Obtained by Immunization with Epitope Peptides and CpG-DNA-liposome Complex.
Park BK; Choi SH; Kim YE; Park S; Lee Y; Lee KW; Kwon HJ
Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):101-9. PubMed ID: 25897608
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immune response to gastric cancer specific antigen Peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion.
Shi R; Hong L; Wu D; Ning X; Chen Y; Lin T; Fan D; Wu K
Cancer Biol Ther; 2005 Feb; 4(2):218-24. PubMed ID: 15753659
[TBL] [Abstract][Full Text] [Related]
10. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
11. Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model.
Kwon S; Kim D; Park BK; Wu G; Park MC; Ha YW; Kwon HJ; Lee Y
Oncol Rep; 2013 Feb; 29(2):735-40. PubMed ID: 23138455
[TBL] [Abstract][Full Text] [Related]
12. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
Kim D; Jung J; Lee Y; Kwon HJ
Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
[TBL] [Abstract][Full Text] [Related]
13. Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.
Li WM; Dragowska WH; Bally MB; Schutze-Redelmeier MP
Vaccine; 2003 Jul; 21(23):3319-29. PubMed ID: 12804863
[TBL] [Abstract][Full Text] [Related]
14. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages.
Yasuda S; Yoshida H; Nishikawa M; Takakura Y
Mol Pharm; 2010 Apr; 7(2):533-42. PubMed ID: 20047296
[TBL] [Abstract][Full Text] [Related]
16. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
[TBL] [Abstract][Full Text] [Related]
17. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
18. HMMC-1, a human monoclonal antibody to fucosylated core 1 O-glycan, suppresses growth of uterine endometrial cancer cells.
Oikawa F; Kojima-Aikawa K; Inoue F; Suzuki A; Tanaka K; Tominaga E; Aoki D
Cancer Sci; 2013 Jan; 104(1):62-9. PubMed ID: 23035753
[TBL] [Abstract][Full Text] [Related]
19. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
[TBL] [Abstract][Full Text] [Related]
20. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
